Damages track upward in US trade secret litigation

But despite a growing emphasis on the topic and a move toward more remote working, overall caseload has been flat

Damages track upward in US trade secret litigation
Legislation to give the ITC more power in trade secrets cases raises many questions
24 Jun 2021

Legislation to give the ITC more power in trade secrets cases raises many questions

The opportunity to shut out competitors after a 30-day investigation would be a powerful tool for businesses, but potentially a very dangerous one too

Supreme Court snub confirms Amarin’s patent disaster
24 Jun 2021

Supreme Court snub confirms Amarin’s patent disaster

The commercial damage resulting from the invalidation of the company’s Vascepa grants is a stark reminder of the dangers of taking biopharma IP disputes to trial

Featured

24 Jun
2021

What Oppo's integration with OnePlus means for IP and licensing within the group

Consolidation of brands under the BBK Electronics banner creates a player with a different patent risk profile Read more

23 Jun
2021

Global innovation needs global thinking on IP and competition law

A country by country approach will not deliver the technology solutions that the Biden Administration and other liberal democracies are searching for as they face up to the challenge of China Read more

23 Jun
2021

The proposed TRIPs covid waiver is a bad idea that could do a lot of good

The Long Read: With Big Pharma being blamed for the slow roll-out of vaccines in medium and low-income countries, Zilber IP’s Einav Zilber argues that the debate over suspending patents, trade secrets and other rights to increase access to jabs is really about the relationship between states and drug companies – and that these issues are not going away Read more

News

View all
20 Jun 2021

Xiaomi IP head urges FRAND royalty rethink; Tesla embraces patents; IP Bridge targets Nordic giants; China solar patent lead; Covid waiver talks begin; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

19 Jun 2021

The new UK innovation tsar will need to drill deep to tackle the country’s patent lag

British businesses have demonstrated their innovative capacity time and again, but their consistent failure to develop the IP that secures it is a problem that must be addressed Read more

13 Jun 2021

DoJ signals SEP shift; German injunction regime change; US patent deals down; Trade secrets move up corporate agenda; Pharma portfolio M&A analysis; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

12 Jun 2021

Increasing diversity in innovation – a call to action

If the US is to compete successfully with China and the rest of the world it must make use of all the talent at its disposal – and that means ensuring more women get to the cutting edge of the invention process Read more

Analysis

View all
23 Jun 2021

Via Licensing looks to extend its hold on audio space with next-gen patent pool

Company president Joe Siino tells IAM the pool operator has secured virtually all the key innovators behind MPEG-H to roll out a unified licensing solution Read more

22 Jun 2021

Arthrex will make IPRs more expensive and uncertain, and the USPTO Director more powerful

The Supreme Court’s keenly-anticipated decision takes the review process even further away from the reasons for its establishment as a relatively quick and cheap way to challenge bad patents Read more

22 Jun 2021

Big questions remain over China’s patent linkage system

Despite amendments coming into force this month, the US-style system has yet to get off the ground Read more

22 Jun 2021

China's high-speed validity trials can be hard to keep up with

CNIPA boasts of "world-leading" time to decision, while some users see a "mad scramble" Read more

Events

View all
9 June
2021

IAM Webinar - Recent Trends in Post Grant Practice

Much has changed before the PTAB since IPRs became available on September 16, 2012. During this webinar we will take a current look at discretionary denials under 35 U.S.C. §§ 314(a) and 325(d) (including administrative challenges to the PTAB’s NHK/Fintiv factors), motion to amend practice, a petitioner’s standing to appeal an adverse IPR determination, and historical statistics on the prevalence and success rates for anticipation and obviousness arguments.

4-5 October
2021

IPBC Europe 2021

Risk free registration now open – the European IP market’s leaders will get back together again in Dublin from 4 to 5 October 2021

Being held at the prestigious Shelbourne Hotel, the event will once again be Europe’s leading gathering of senior corporate IP professionals from companies of all sizes.

14-16 November
2021

IPBC Global 2021

IPBC Global will bring the world’s IP business leaders back together again in 2021 when it reconvenes in Seattle, the fastest growing tech hub in the USA and home to some of the most innovative businesses on the planet.

From 14 to 16 November 2021, attendees at the world’s leading IP event will enjoy unsurpassed networking and deal-making opportunities, as well as the chance to join high-level discussion around the key challenges facing those responsible for developing IP business strategies now and into the future.

Insights

4 Nov 2020

Supreme Court could signal time’s up for Google’s anti-competitive IP infringement

A long-running battle with Oracle once again shines the spotlight on a pattern of alleged major IP infringements by the search giant Read more

12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

IP Market news highlights

IAM’s biggest spring reads Read more

Analysis

Latest analysis reports from IAM.

Thought leadership

IAM offers an extensive range of special reports.

Why subscribe?

Our team of analysts, reporters and researchers ensures that we cover the issues that truly matter to IP decision makers. Deep-dive analysis and insight deliver actionable takeaways designed to be applied in the business environment.